ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Xu Wang
Matched on OpenAlex author ID A5143552879. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2026: 2 papers
Papers 2
- Comparative evaluation of chemotherapy and CAR-T cell therapy in genetically engineered self-sustaining primary pancreatic cancer organoids. Co-author DOI 10.1016/j.pan.2026.07.013↗
- Corrigendum to "Wang X, Wang R, Lin X et al. Comparative evaluation of chemotherapy and CAR-T cell therapy in genetically engineered self-sustaining primary pa… Co-author DOI 10.1016/j.pan.2026.09.001↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- He Cheng · 2 shared papers, 2026 · strength 0.51
- Paper Comparative evaluation of chemotherapy and CAR-T cell therapy in genetically engineered self-sustaining primary pancrea… DOI 10.1016/j.pan.2026.07.013↗
- Paper Corrigendum to "Wang X, Wang R, Lin X et al. Comparative evaluation of chemotherapy and CAR-T cell therapy in genetical… DOI 10.1016/j.pan.2026.09.001↗
- Xianjun Yu · 2 shared papers, 2026 · strength 0.51
- Paper Comparative evaluation of chemotherapy and CAR-T cell therapy in genetically engineered self-sustaining primary pancrea… DOI 10.1016/j.pan.2026.07.013↗
- Paper Corrigendum to "Wang X, Wang R, Lin X et al. Comparative evaluation of chemotherapy and CAR-T cell therapy in genetical… DOI 10.1016/j.pan.2026.09.001↗
- Chen Liu · 2 shared papers, 2026 · strength 0.51
- Paper Comparative evaluation of chemotherapy and CAR-T cell therapy in genetically engineered self-sustaining primary pancrea… DOI 10.1016/j.pan.2026.07.013↗
- Paper Corrigendum to "Wang X, Wang R, Lin X et al. Comparative evaluation of chemotherapy and CAR-T cell therapy in genetical… DOI 10.1016/j.pan.2026.09.001↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.